Loading…
DIA Europe 2019 has ended
avatar for Michael Forstner

Michael Forstner

PrimeVigilance
Senior Vice President, Head of Risk Management and Pharmacoepidemiology
Michael's main focus areas are the planning, development, implementation and evaluation of benefit-risk management solutions, as well as the optimization of processes around benefit-risk management. He is engaged in developing and applying (benefit-) risk analysis methodologies in order to make RM planning more formally reproducible. Furthermore, he supports the development, implementation and evaluation of effectiveness of additional risk minimization and PV measures in the context of RMPs, as well as post-authorization studies to optimize the benefit-risk profiles of medicines.

My Speakers Sessions

Monday, February 4
 

14:00 CET